Cargando…
Brain Targeted AAV1-GALC Gene Therapy Reduces Psychosine and Extends Lifespan in a Mouse Model of Krabbe Disease
Krabbe disease (KD) is a progressive and devasting neurological disorder that leads to the toxic accumulation of psychosine in the white matter of the central nervous system (CNS). The condition is inherited via biallelic, loss-of-function mutations in the galactosylceramidase (GALC) gene. To rescue...
Autores principales: | Herdt, Aimee R., Peng, Hui, Dickson, Dennis W., Golde, Todd E., Eckman, Elizabeth A., Lee, Chris W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10454254/ https://www.ncbi.nlm.nih.gov/pubmed/37628569 http://dx.doi.org/10.3390/genes14081517 |
Ejemplares similares
-
Psychosine enhances the shedding of membrane microvesicles: Implications in demyelination in Krabbe’s disease
por: D’Auria, Ludovic, et al.
Publicado: (2017) -
rAAV2-Mediated Restoration of GALC in Neural Stem Cells from Krabbe Patient-Derived iPSCs
por: Tian, Guoshuai, et al.
Publicado: (2023) -
The Pathogenic Sphingolipid Psychosine is Secreted in Extracellular Vesicles in the Brain of a Mouse Model of Krabbe Disease
por: Reiter, Cory R., et al.
Publicado: (2022) -
Newborn Screening for Krabbe Disease—Illinois Experience: Role of Psychosine in Diagnosis of the Disease
por: Basheeruddin, Khaja, et al.
Publicado: (2021) -
Low Psychosine in Krabbe Disease with Onset in Late Infancy: A Case Report
por: Corre, Camille S., et al.
Publicado: (2021)